Free Trial

Evogene (EVGN) Competitors

Evogene logo
$1.38 -0.01 (-0.36%)
Closing price 03:39 PM Eastern
Extended Trading
$1.44 +0.06 (+4.65%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EVGN vs. ENFY, TOMZ, BSLK, GURE, NITO, DNMR, SNES, CNEY, TANH, and GAMCW

Should you be buying Evogene stock or one of its competitors? The main competitors of Evogene include Enlightify (ENFY), TOMI Environmental Solutions (TOMZ), Bolt Projects (BSLK), Gulf Resources (GURE), N2OFF (NITO), Danimer Scientific (DNMR), SenesTech (SNES), CN Energy Group. (CNEY), Tantech (TANH), and Golden Arrow Merger (GAMCW). These companies are all part of the "chemicals" industry.

Evogene vs.

Enlightify (NYSE:ENFY) and Evogene (NASDAQ:EVGN) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, profitability and community ranking.

Evogene has lower revenue, but higher earnings than Enlightify. Enlightify is trading at a lower price-to-earnings ratio than Evogene, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enlightify$87.36M0.18-$28.41M-$1.98-0.55
Evogene$8.51M0.87-$23.88M-$3.11-0.45

0.1% of Enlightify shares are held by institutional investors. Comparatively, 10.4% of Evogene shares are held by institutional investors. 38.2% of Enlightify shares are held by insiders. Comparatively, 7.4% of Evogene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Evogene received 221 more outperform votes than Enlightify when rated by MarketBeat users.

CompanyUnderperformOutperform
EnlightifyN/AN/A
EvogeneOutperform Votes
221
54.03%
Underperform Votes
188
45.97%

In the previous week, Evogene had 1 more articles in the media than Enlightify. MarketBeat recorded 1 mentions for Evogene and 0 mentions for Enlightify. Enlightify's average media sentiment score of 0.00 equaled Evogene'saverage media sentiment score.

Company Overall Sentiment
Enlightify Neutral
Evogene Neutral

Evogene has a consensus price target of $12.00, suggesting a potential upside of 765.80%. Given Evogene's stronger consensus rating and higher probable upside, analysts plainly believe Evogene is more favorable than Enlightify.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enlightify
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Evogene
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Enlightify has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, Evogene has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Enlightify has a net margin of -31.34% compared to Evogene's net margin of -314.43%. Enlightify's return on equity of -26.06% beat Evogene's return on equity.

Company Net Margins Return on Equity Return on Assets
Enlightify-31.34% -26.06% -16.39%
Evogene -314.43%-109.05%-52.55%

Summary

Evogene beats Enlightify on 10 of the 16 factors compared between the two stocks.

Remove Ads
Get Evogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVGN vs. The Competition

MetricEvogeneAgricultural chemicals IndustryMedical SectorNASDAQ Exchange
Market Cap$7.44M$4.35B$5.72B$8.09B
Dividend YieldN/A3.98%4.41%4.08%
P/E Ratio-0.3135.8824.1518.97
Price / Sales0.873.98394.1189.89
Price / CashN/A7.3138.1134.64
Price / Book0.200.946.934.35
Net Income-$23.88M$314.10M$3.18B$246.92M
7 Day Performance-3.08%0.23%1.05%1.35%
1 Month Performance-2.19%-9.41%1.67%-6.52%
1 Year Performance-82.34%-40.58%14.41%3.35%

Evogene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVGN
Evogene
1.4544 of 5 stars
$1.38
-0.4%
$12.00
+772.7%
-82.7%$7.38M$8.51M-0.31140Analyst Forecast
ENFY
Enlightify
N/A$1.12
-0.9%
N/AN/A$16.18M$87.36M-0.55424Gap Down
TOMZ
TOMI Environmental Solutions
2.9939 of 5 stars
$0.78
-6.0%
$3.50
+348.7%
+12.2%$15.61M$8.20M-6.0020News Coverage
Gap Up
BSLK
Bolt Projects
N/A$0.34
-8.7%
N/AN/A$11.61M$2.15M0.0012Earnings Report
News Coverage
Gap Down
GURE
Gulf Resources
0.2076 of 5 stars
$0.72
-1.4%
N/A-37.3%$7.72M$12.80M-0.08420Short Interest ↑
NITO
N2OFF
1.3518 of 5 stars
$0.29
-3.3%
N/AN/A$4.45M$175,308.000.002Short Interest ↓
Positive News
Gap Down
DNMR
Danimer Scientific
0.9683 of 5 stars
$1.11
-1.8%
$13.83
+1,146.2%
-99.4%$3.35M$37.43M-0.03280Upcoming Earnings
News Coverage
Gap Down
SNES
SenesTech
2.0394 of 5 stars
$2.35
-21.9%
$10.00
+325.5%
-70.8%$2.43M$1.65M0.0030Gap Down
High Trading Volume
CNEY
CN Energy Group.
0.1009 of 5 stars
$0.17
-5.6%
N/A-84.6%$1.20M$50.96M0.00160Gap Down
TANH
Tantech
0.1009 of 5 stars
$2.87
-5.3%
N/A-90.9%$273,000.00$49.10M0.0070
GAMCW
Golden Arrow Merger
N/A$0.04
flat
N/AN/A$0.00N/A0.0012
Remove Ads

Related Companies and Tools


This page (NASDAQ:EVGN) was last updated on 3/21/2025 by MarketBeat.com Staff
From Our Partners